logo
Book a meeting
ProfoundBio

Profound Bio

Biotechnology, Woodinville, Washington, United States, 51-200 Employees

profoundbio.com

  • LinkedIn

Who is PROFOUNDBIO

ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally...

Read More

lock icon Get Full Access
map
  • Woodinville, Washington, United States Headquarters: Woodinville, Washington, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 28 | NAICS Code: 32 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PROFOUNDBIO

ProfoundBio Org Chart and Mapping

Employees
Sharon Ma

Sharon Ma

Director, Clinical Operations

Xin Shen

Xin Shen

Senior Finance and Accounting Manager

See Full Org Chart arrow
email-formate-icon
View Email Formats for ProfoundBio
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding ProfoundBio

Answer: ProfoundBio's headquarters are located at Woodinville, Washington, United States

Answer: ProfoundBio's official website is https://profoundbio.com

Answer: ProfoundBio's revenue is $10 Million to $25 Million

Answer: ProfoundBio's SIC: 28

Answer: ProfoundBio's NAICS: 32

Answer: ProfoundBio has 51-200 employees

Answer: ProfoundBio is in Biotechnology

Answer: ProfoundBio contact info: Phone number: Website: https://profoundbio.com

Answer: ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages. The Companys clinical stage programs are rinatabart sesutecan (Rina-S; PRO1184), an ADC targeting folate receptor alpha, PRO1160, an ADC targeting CD70, and PRO1107, an ADC targeting PTK7. ProfoundBio is headquartered in Seattle, WA, USA.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access